CClinicalTrials.gg
CompletedNCT00507273Updated Aug 2, 2012

Gastrointestinal Stromal Tumors (GIST) Registry

An observational study in Gastrointestinal Stromal Tumors, sponsored by M.D. Anderson Cancer Center. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2012-08-02.

Sponsored by M.D. Anderson Cancer Center · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1,800
Sex
All
01

Study summary

The goal of this observational research study is to establish a registry of information regarding how different physicians treat and manage patients with gastrointestinal stromal tumors (GISTs).

Objectives:

  1. To describe variation in management of patients with GIST, overall and by patient and provider characteristics.
  2. To provide participating physicians with information regarding management of their patients with GIST compared to the aggregate experience of all physicians participating in the Registry.
Read the detailed description

The Registry, which is Internet based, is intended to collect information about current practices in the management of GIST without making any specific change to the standard of care as decided by each patient's treating physician.

If you agree to participate in this study, your doctor will provide information to a data registry about your physical and clinical traits, the past and current medical care you have received to treat your GIST, and clinically-related, economically-related, and health-related quality of life information. About 200 doctors will provide information on their patients for the Registry. Your doctor will collect this information when you first join the Registry and at each regularly scheduled visit you make to your doctor's office. The information collection will continue for as long as you and your doctor feel it is appropriate. The information that is entered into the Registry will remain there indefinitely. It is hoped that this sharing of information will lead to a better understanding of how to best treat patients with GIST.

You and your doctor will decide what treatment you will receive. Because this Registry is only to observe actual medical practice, it does not require you to receive any particular treatment.

Only your doctor and people who will help your doctor collect the information for this Registry will know which information submitted to the Registry belongs to you. Data will be tracked in the Registry using only ID numbers and patient initials. The information submitted on the Registry data collection forms will not be associated with a specific patient's identity. Separately, you will be asked to provide your name, place of birth, and Social Security number. This information will not be entered into the Registry databases and will only be used if it is necessary to perform a search should you become lost to follow up. If you do not want to provide your Social Security number you may still be enrolled in the Registry.

This is an investigational study. About 100 patients from M. D. Anderson will be entered into the Registry. In all, about 1800 patients will be registered. The Registry will be active for at least 7 years.

02

Conditions studied

  • Gastrointestinal Stromal Tumors

Keywords

  • Gastrointestinal Stromal Tumors
  • Gastrointestinal Cancer
  • GISTs
  • GIST Registry
  • Registry
03

In context

Gastrointestinal Stromal Tumors

333 studies on the registry are indexed under Gastrointestinal Stromal Tumors; 61 are open to participants now.

This study's enrollment of 1,800 is above the median of 116 across 68 observational studies indexed under Gastrointestinal Stromal Tumors.

Browse Gastrointestinal Stromal Tumors studies →

Lead sponsor

M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 581 are open to participants now.

Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients diagnosed with a gastrointestinal stromal tumor (GIST).

Inclusion criteria

  1. All patients who have been diagnosed with GIST are eligible for enrollment.

Exclusion criteria

Exclusion Criteria:

  1. Patients with a histologic diagnosis other than gastrointestinal stromal tumor (GIST).
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1,800 participants (actual)

Groups and cohorts

  • GIST

    Patients diagnosed with a gastrointestinal stromal tumor (GIST)

    Other: GIST Registry

Interventions

  • OtherGIST Registry

    Internet based data registry about how different physicians treat and manage patients with gastrointestinal stromal tumors.

06

What researchers measure

Primary outcomes

  1. Current patterns of medical practice in management of patients with GIS

    Data from observational GIST Registry analyzed to describe current patterns.

    Time frame: 5 Years

07

Study locations

1 site
  • UT MD Anderson Cancer Center
    Houston, Texas 77030, United States
08

References and documents

Publications

  • Pisters PWT, Blanke CD, von Mehren M, Picus J, Sirulnik A, Stealey E, Trent JC; reGISTry Steering Committee. A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices. Ann Oncol. 2011 Nov;22(11):2523-2529. doi: 10.1093/annonc/mdq773. Epub 2011 Apr 4. PubMed 21464155 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 2, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00507273
Lead sponsor
M.D. Anderson Cancer Center
Collaborators
Novartis Pharmaceuticals
Responsible party
Sponsor
First posted
Jul 26, 2007
Start date
Aug 2005
Primary completion
Dec 2010
Completion
Dec 2010
Last update
Aug 2, 2012

Study contacts

Jonathon Trent, MD, PhD
principal investigator · M.D. Anderson Cancer Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion